It is at this stage difficult to make clear-cut correlations between GDNF and APP soluble fragments in human samples because of the reduced number of ALS patients enrolled in the study, the variability existing between them and especially because of the peculiarity of disease history. The gene discussed is GDNF; the disease is amyotrophic lateral sclerosis.